- Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?2015 | First Faculty of Medicine
- Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody - Associated Vasculitis2018 | First Faculty of Medicine
- Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives2020 | First Faculty of Medicine
- Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody - associated vasculitis: a randomized controlled trial2010 | First Faculty of Medicine
- Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis2008 | First Faculty of Medicine
- Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis2008 | Publication without faculty affiliation
- Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial2009 | First Faculty of Medicine
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis2017 | First Faculty of Medicine
- Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study2023 | First Faculty of Medicine
- Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations2023 | First Faculty of Medicine
- Effect of Treatment on Damage and Hospitalization in Elderly Patients with Microscopic Polyangiitis and Granulomatosis with Polyangiitis2020 | First Faculty of Medicine
- Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience2004 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- ANCA Vasculitis Induction Management During the COVID-19 Pandemic2021 | First Faculty of Medicine
- Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts2017 | First Faculty of Medicine
- Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases2021 | First Faculty of Medicine
- Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying2024 | First Faculty of Medicine
